Pennsylvania Trust Co purchased a new position in Livent Corporation (NASDAQ:LTHM) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 110,135 shares of the company’s stock, valued at approximately $9,572,000.
Several other institutional investors and hedge funds also recently bought and sold shares of the company. FMR LLC purchased a new position in shares of Livent in the 4th quarter worth about $30,461,000. BlackRock Inc. purchased a new position in shares of Livent in the 4th quarter worth about $21,491,000. CIBC Private Wealth Group LLC purchased a new position in shares of Livent in the 4th quarter worth about $18,402,000. Emerald Advisers LLC purchased a new position in Livent in the 4th quarter worth about $11,923,000. Finally, Emerald Mutual Fund Advisers Trust purchased a new position in Livent in the 4th quarter worth about $10,667,000.
A number of brokerages have weighed in on LTHM. Credit Suisse Group set a $20.00 target price on Livent and gave the stock a “buy” rating in a research report on Friday, January 4th. Nomura lowered Livent from a “buy” rating to a “neutral” rating in a research report on Tuesday, January 15th. Gabelli began coverage on Livent in a research report on Wednesday, February 27th. They issued a “buy” rating and a $21.00 target price for the company. Zacks Investment Research raised Livent from a “hold” rating to a “strong-buy” rating and set a $15.00 target price for the company in a research report on Friday, December 28th. Finally, Clarkson Capital began coverage on Livent in a research report on Wednesday, January 16th. They issued a “buy” rating and a $20.00 target price for the company. Five analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. Livent presently has a consensus rating of “Buy” and an average target price of $18.71.
Livent (NASDAQ:LTHM) last announced its quarterly earnings data on Monday, February 11th. The company reported $0.23 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.23. The company had revenue of $119.80 million for the quarter, compared to the consensus estimate of $124.70 million.
COPYRIGHT VIOLATION WARNING: “Pennsylvania Trust Co Purchases Shares of 110,135 Livent Corporation (LTHM)” was first published by Baseball Daily News and is the sole property of of Baseball Daily News. If you are reading this piece of content on another website, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.baseballdailydigest.com/news/2019/04/24/pennsylvania-trust-co-purchases-shares-of-110135-livent-corporation-lthm.html.
Livent Corporation manufactures and sells performance lithium compounds that are used primarily in energy storage, specialty polymers, and chemical synthesis application. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and supplies butyllithium, which is used as a synthesizer in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in the production of lightweight materials for aerospace applications and non-rechargeable batteries.
Further Reading: What is a Buy-Side Analyst?
Want to see what other hedge funds are holding LTHM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Livent Corporation (NASDAQ:LTHM).
Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.